| Updated on February 02, 2018 Published on May 17, 2017

Please find enclosed a Press Release on Dr. Reddys Laboratories announces USFDA approval for the launch of Doxorubicin Hydrochloride Liposome Injection in the U.S. Market. This is for your information.

Pdf Link: Updates

Source : BSE - www.bseindia.com

Published on May 17, 2017
This article is closed for comments.
Please Email the Editor